Can This Struggling Industry Bounce Back?

Three of the medical device industry's biggest names have a lot riding on the cardiac rhythm management industry. Cardiac powerhouses Boston Scientific (NYSE: BSX  ) and St. Jude Medical (NYSE: STJ  ) , as well as the market's largest pure medical device maker, Medtronic (NYSE: MDT  ) , all draw a substantial portion of revenue from this hard-hit niche that's seen a slowdown in Europe and heightened rivalry in the industry pressure sales over the past few years. But can these top companies turn around sales losses?

Credit Medtronic for doing its best: This leading device maker has pushed for smaller pacemakers as it looks to inject growth in a sluggish business. Meanwhile, St. Jude and Boston Scientific have celebrated new approvals in this industry from U.S. regulators, but neither saw great performance from CRM revenue in their recent quarterly earnings reports.

Boston Scientific's stock in particular has thrived over the past year despite the ongoing CRM sluggishness, but can these top device picks keep charging higher? Find out in the video below, as Motley Fool contributor Dan Carroll takes you through how these companies rely so much on the CRM industry -- and whether you can count on a turnaround soon in this stumbling business.

Will this stock be your next multi-bagger?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2947948, ~/Articles/ArticleHandler.aspx, 7/28/2014 10:54:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement